Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-09-23

FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for AZOR (amlodipine besylate and olmesartan medoxomil) submitted by Cosette Pharmaceuticals, Inc., to update the produc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZOR (Amlodipine besylate and olmesartan medoxomil)

Snippet

SUPPL AP for AZOR (AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL)